Volpara (ASX: VHT) Reports Minimal Cash Burn In Q1 FY 2024
Volpara (ASX: VHT) remains close to profitability in Q1 FY 2024, showing good cost control and continuing revenue growth.
Volpara Health Technologies (ASX: VHT)
10 ASX Small Cap Quarterly Updates At A Glance
10 quarterly snapshots: Raiz (ASX: RZI), Volpara (ASX: VHT), SciDev (ASX: SDV), NextEd (ASX: NXD), Ensurance (ASX: ENA), Playside Studios, Wisr (ASX: WZR) and more…
Volpara (ASX: VHT) Q4 FY 2022 Strong But Outlook Cloudy
Volpara (ASX: VHT) has experienced impressive growth in annualised recurring revenue over the last five years; but it’s still uncomfortably far from profitability.
IntelliHR (ASX:IHR), Rightcrowd (ASX:RCW), and Volpara (ASX:VHT) December 2021 Quarterly Reports
Quarterly reports of Rightcrowd, IntelliHR and Volpara update us on free cash flow and annualised recurring revenue growth…
My Target Buy Prices For High Quality Fluffy Dogs
Even though growth stocks are down considerably, in my view the top quality growth stocks are still up pretty overvalued.
ApplyFlow (ASX:AFW), 8Common (ASX:8CO) and Volpara (ASX:VHT) Quarterly Reports
These growth stocks are still losing money, but seem to be heading in the right direction.
5 Fluffy Dog Growth Stocks To Buy If Markets Keep Falling
These five stocks all have very high quality businesses that I want to buy more shares in, if only the market would offer a slightly better price.
Why Volpara (ASX: VHT) Is A Good Business For Ethical Investors To Follow
Volpara is on a mission to increase early detection of breast cancer.
What Growing ASX Software Stock Should I Buy Today?
Some stocks have high multiples and higher growth rates, others have lower multiples and lower growth rates. Here’s how I decided which one to choose.
Why I Just Bought More Volpara (ASX: VHT) Shares
The Volpara share price has been languishing for quite some time, but the opportunity to expand from mammograms to lung scans is promising…
Volpara Health Technologies Ltd (ASX: VHT) Share Price Flat, ARR Up
Volpara (ASX: VHT) has a winning product but its pattern of expanding through acquisitions funded by capital raises poses questions for long-term investors.
Volpara (ASX: VHT) share price rises, but Covid-19 impact remains unclear
Tuesday morning’s market announcement spruiked strong underlying financials, but the effect of Covid-19 on non-infectious medical procedures remains to be seen.